Pérez, A., Mezquita Raya, P., Ramírez de Arellano, A., Briones, T., Hunt, B., & Valentine, W. J. (2015). Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin. Diabetes Ther.

Pérez, Antonio, Pedro Mezquita Raya, Antonio Ramírez de Arellano, Teresa Briones, Barnaby Hunt, and William J. Valentine. "Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin." Diabetes Ther 2015.

Pérez, Antonio, et al. "Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin." Diabetes Ther 2015.